专利检索 ap:("Bayer Schering Pharma Aktiengesellschaft") AND inv:"MÖLLER, Carsten" 第 1 页

1.

发明公开
SEQUENTIELLE VERARBEITUNG VON 20,20,21,21-PENTAFLUOR-17-HYDROXY-11 -Ý4-(HYDROXYACETYL) PHENYL¨-19-NOR-17 -PREGNA-4,9-DIEN-3-ON UND EINEM ODER MEHREREN GESTAGENEN ZUR BEHANDLUNG GYNÄKOLOGISCHER ERKRANKUNGEN 审中-公开
标题翻译：按顺序处理的20,20,21,21五氟-17-羟基-11--Ý4-（羟基乙酰基）苯基-19-降-17-孕-4,9-二烯-3-酮和一种或多种孕激素为妇科疾病治疗

公开(公告)号：EP2285383A2

公开(公告)日：2011-02-23

申请号：EP09745520.8

申请日：2009-05-07

申请人： Bayer Schering Pharma Aktiengesellschaft

发明人： FUHRMANN, Ulrike , SCHWEDE, Wolfgang , MÖLLER, Carsten

IPC分类号： A61K31/567 , A61P5/34 , A61P5/36

CPC分类号： A61K31/567 , A61K31/57 , A61K31/585 , A61K2300/00

摘要： The invention relates to a treatment regime and to combination preparations of 20,20,21,21,21 -pentafluoro-17-hydroxy-11 ß-[4- (hydroxyacetyl)phenyl]-19-nor-17α-pregna-4,9-diene-3-one of formula (I). Said invention relates to, in particular, a sequential regime for treating gynaecological diseases in which, in a first phase, the above-mentioned progesterone antagonist is administered and, in a second phase, a progestational hormone is administered.